Connect with us
Information

WORLD EDITION
Australia
North America
World

Investing News NetworkYour trusted source for investing success

WORLD EDITION
North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

apellis pharmaceuticals

POPULAR ARTICLES

Pharmaceutical Investing

Apellis Pharmaceuticals Announces Collaboration with SFJ Pharmaceuticals® for APL-2 in Hematologic Indications

Apellis Pharmaceuticals’ APL-2 Receives Orphan Drug Designation from the FDA

Apellis Pharmaceuticals Provides Update on Its Phase 3 Program for Patients with Geographic Atrophy

LATEST ARTICLES

Apellis Pharmaceuticals Presents New Data from Ongoing APL-2 Phase 2 Study

Latest News

Precious Metals & Critical Minerals Hybrid Investor Conference: Presentations Now Available for Online Viewing

Forte Minerals Announces Private Placement of up to C$2.4 Million

Group Eleven Announces Uplisting to OTCQB Market

Thick High-Grade Graphite Drilling Results In New Zone

Analyst Report Eyes 227% Upside for Brightstar Resources as Gold Production Nears